<SEC-DOCUMENT>0001129928-22-000063-index.html : 20220518
<SEC-HEADER>0001129928-22-000063.hdr.sgml : 20220518
<ACCEPTANCE-DATETIME>20220517201132
ACCESSION NUMBER:		0001129928-22-000063
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220518
DATE AS OF CHANGE:		20220517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38512
		FILM NUMBER:		22936671

	BUSINESS ADDRESS:	
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2R 0C5
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2R 0C5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a2022informationcircularfo.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: a2022informationcircularfo.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>finalonccircular2022.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: finalonccircular2022.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>oncolytics-proxydraft.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 3 - file: oncolytics-proxydraft.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_2a.jpg
<TEXT>
Document 4 - file: image_2a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>oncolytics-proxydraft001.jpg
<TEXT>
Document 5 - file: oncolytics-proxydraft001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>oncolytics-proxydraft002.jpg
<TEXT>
Document 6 - file: oncolytics-proxydraft002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>performance_graphx2022a.jpg
<TEXT>
Document 7 - file: performance_graphx2022a.jpg

</DOCUMENT>
</SEC-DOCUMENT>